Post-Hoc Analysis of DAPA-HF: Dapagliflozin Use Is Associated With Rapid Reduction of Cardiovascular Death Among Patients With Heart Failure With Reduced Ejection Fraction
A recent study by Dr. David D. Berg, published in JAMA Cardiology,…
REPLACE COVID Trial: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Can Be Safely Continued in Patients Admitted to Hospital With COVID-19
A recent trial by Dr. Jordana B Cohen, published in The LANCET, indicated that…
EMPEROR-Reduced Trial: Empagliflozin Use Was Associated With a Better Clinical Outcomes Among Patients With Heart Failure and a Reduced Ejection Fraction
A recent study by Dr. Milton Packer, published in Circulation, demonstrated that…
DAPA Trial: Prophylactic Defibrillator Implantation After Primary Percutaneous Coronary Intervention Lowers Long Term Mortality in Patients at High Risk of Death
Results of the DAPA trial, published in Circulation: Arrhythmia and Electrophysiology, demonstrated…
Study Shows Aortic Valve Replacement Was Associated With Better Outcomes in Patients with Low-Gradient Aortic Stenosis and Preserved Left Ventricular Ejection Fraction Compared With High-Gradient Aortic Stenosis
A recent study by Dr. Salaun, published in Circulation: Cardiovascular Interventions, demonstrated…
DAPA-HF Trial: Compared to Placebo, Dapagliflozin Was Beneficial in Patients with Heart Failure and Reduced Ejection Fraction Regardless of Background Diuretic Therapy
A recent study by Dr. Alice M. Jackson M.D., published in Circulation…
Integrated Management of Atrial Fibrillation in Primary Care Demonstrates 45% Reduction in All-Cause Mortality Compared to Usual Care in Elderly Patients
In a recent Dutch study, published in European Heart Journal, integrated care for…
Cohort Study Showed a Large Number of Patients Receiving Anticancer Therapy Demonstrate Myocardial Injury or Left Ventricular Dysfunction, With Only Few Showing Severe Cardiotoxicity
A recent study by Dr. Lopez-Sendon, published in European Heart Journal, showed…
Study Shows Hepatitis C Status Not Associated With Adverse Events in Adult Heart Transplant Patients by 1 Year
A recent study by Dr. Kilic, published in the American Heart Association…
Elevated Coronary Sinus Neuropeptide Y Levels Are Associated With Adverse Outcomes in Patients With Chronic Heart Failure
The study by Dr. Ajijola, published in JAMA Cardiology, found that elevated…
The Sarcomeric Human Cardiomyopathy Registry: Race Associated with Disease Expression and Clinical Outcomes Among Patients with Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited genetic disorder of the…
Nationwide Study Shows New-onset Left Bundle Branch Block After Transcatheter Aortic Valve Replacement Occurred in 15% of Intermediate Risk Patients and Is Associated with Worse 2 Year Outcomes
According to a new nationwide study, new onset left bundle branch block…
Meta-analysis Shows Vitamin D Supplementation Does Not Improve Cardiovascular Outcomes
In the largest updated meta-analysis study conducted to understand the inverse association…
New 22 Year Follow Up Study Shows Bariatric Surgery Associated with Lower Risk of Heart Failure in Obese Patients
In a study published in the European Heart Journal, Dr. Shabbar Jamaly…
A 5% Absolute Increase in Influenza Activity Associated with a 24% Increase in Heart Failure Hospitalizations, According to New Study
A study conducted by Sonja Kytömaa and Sheila Hegde of the cardiovascular…
Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior MI
According to a presentation by Dr. Marc P. Bonaca at the American…
HeartMate3 Found to be More Superior Than Other LVADs on Endpoints of Stroke, Pump Thrombosis and Bleeding Complications
The largest LVAD trial ever to be performed, led by Dr. Mandeep…
Findings From a Randomized Controlled Trial May Usher the Adoption of Angiotensin–Neprilysin Inhibition to the Heart-Failure Armamentarium
The results of a trial presented by Dr. Adam DeVore at the…
U.S. Food and Drug Administration (FDA) Continues To Investigate Recall of Contaminated Blood Pressure Medication
The US food and drug Administration (FDA) has recently been conducting an…
Did the Hospital Readmissions Reduction Program Impact Heart Failure Readmission or Mortality?
An article by Sandhu et al. published in the American Heart Journal…